Peter C. Warnke
Impact in
Papers in
- Co-authors
- Christoph B. Ostertag (14 shared papers)Friedrich Wilhelm Kreth (12 shared papers)Zvi Ram (3 shared papers)Manfred Westphal (3 shared papers)Patrick Delavault (2 shared papers)Ian Roger Whittle (2 shared papers)Enoch B. Bortey (2 shared papers)Robert Olivares (2 shared papers)
- Journals
- Journal of Neurology Neurosurgery & Psychiatry (17 papers)Neurosurgery (13 papers)Journal of Neuro-Oncology (9 papers)Neurology (9 papers)Epilepsy & Behavior (6 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Peter C. Warnke
152 papers receiving 5.3k citations
Peter C. Warnke's Hit Papers
Peers
Comparison fields: 5 of 132
- Genetics 2.1k
- Neurology 1.1k
- Biomaterials 462
- Cellular and Molecular Neuroscience 579
- Neurology 243
Countries citing papers authored by Peter C. Warnke
This map shows the geographic impact of Peter C. Warnke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter C. Warnke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter C. Warnke more than expected).
Fields of papers citing papers by Peter C. Warnke
This network shows the impact of papers produced by Peter C. Warnke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter C. Warnke. The network helps show where Peter C. Warnke may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter C. Warnke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 157 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma Hit paper breakdown → | 2003 | 1103 |
| 2 | 1995 | 441 | |
| 3 | 2014 | 239 | |
| 4 | 1993 | 202 | |
| 5 | 2013 | 195 | |
| 6 | 2014 | 147 | |
| 7 | 2003 | 132 | |
| 8 | 2013 | 100 | |
| 9 | 1999 | 98 | |
| 10 | 2018 | 88 | |
| 11 | 2006 | 85 | |
| 12 | 2017 | 83 | |
| 13 | 2003 | 79 | |
| 14 | 2006 | 78 | |
| 15 | 2012 | 75 | |
| 16 | 1997 | 68 | |
| 17 | 2011 | 67 | |
| 18 | 1991 | 66 | |
| 19 | 2017 | 65 | |
| 20 | 2018 | 64 |
About Peter C. Warnke
Peter C. Warnke is a scholar working on Genetics, Neurology, Cellular and Molecular Neuroscience, Psychiatry and Mental health and Cognitive Neuroscience, having authored 157 papers that have together received 5.6k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (52 papers), Epilepsy research and treatment (25 papers), Neurological disorders and treatments (24 papers), Brain Metastases and Treatment (15 papers), Meningioma and schwannoma management (13 papers), EEG and Brain-Computer Interfaces (12 papers), Cerebrospinal fluid and hydrocephalus (10 papers) and Neuroscience and Neuropharmacology Research (10 papers). The work is most often cited by research in Genetics (2.1k citations), Neurology (1.1k citations), Biomaterials (462 citations), Cellular and Molecular Neuroscience (579 citations) and Neurology (243 citations). Peter C. Warnke has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Christoph B. Ostertag, Friedrich Wilhelm Kreth, Zvi Ram, Manfred Westphal, Patrick Delavault, Ian Roger Whittle, Enoch B. Bortey, Robert Olivares, Dana C. Hilt and Juha E. Jääskeläinen. Their work appears in journals such as Journal of Neurology Neurosurgery & Psychiatry, Neurosurgery, Journal of Neuro-Oncology, Neurology and Epilepsy & Behavior.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.